Autoimmune Diseases  >>  DegludecPlus (insulin degludec/insulin aspart)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DegludecPlus (insulin degludec/insulin aspart) / Novo Nordisk
BOOST, NCT00978627 / 2008-005769-71: Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Checkmark Data
Sep 2011 - Sep 2011: Data
Checkmark Data
Jun 2011 - Jun 2011: Data
Completed
3
548
US, Europe, RoW
insulin degludec/insulin aspart, insulin detemir, insulin aspart
Novo Nordisk A/S
Diabetes, Diabetes Mellitus, Type 1
05/10
05/10

Download Options